Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer

MONDAY, Oct. 22, 2018 -- For patients with metastatic triple-negative breast cancer, atezolizumab plus nanoparticle albumin-bound (nab)-paclitaxel prolongs progression-free survival compared with placebo plus nab-paclitaxel, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news